Bismuth Subsalicylate 262 Mg Tablet, Chewable
Product Images NDC 69618-029

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bismuth Subsalicylate 262 Mg (NDC 69618-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reliable 1 Laboratories Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2e92d053 1618 143b E054 00144ff8d46c

Close-up image of a pink, round chewable tablet of Bismuth Subsalicylate 262 mg, orally administered. The tablet features an imprint that includes a triangle symbol with the letter 'P' inside, above the number '045'. The background is black, and the text below identifies the product name and strength.*

FDA Label Image

Bismuth (369618029033 Bismuth Subsalicylate Chew Tablets 262 mg)

Drug Facts text panel for Bismuth Subsalicylate 262 mg chewable tablets by Reliable 1 Laboratories LLC. The panel includes active ingredient, purpose, uses, warnings, directions, and other consumer information related to this upset stomach reliever/antidiarrheal product in a 30-count package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.